Impact of Brexit on NHS: An Increase of 1,485 Deaths Annually Due to Loss of EU Nurses

A recent study from the University of Surrey highlights the significant impact of Brexit on the UK's National Health Service (NHS), revealing that the departure of EU nurses following the 2016 referendum has resulted in approximately 1,485 additional deaths per year within three years post-referendum. The research analyzed administrative data from 131 English NHS hospitals, focusing on the pre-referendum proportion of EU nurses—ranging from 0.5% to 22%, with an average of about 5.84%—and how their departure affected hospital care quality.
The findings demonstrate a marked decline in the influx of EU nurses after Brexit, coupled with a rise in the employment of non-EU overseas nurses, who often possessed less experience and received lower pay. The study concludes that this shift in workforce composition was the primary driver behind the increased mortality and healthcare readmissions, as other factors such as patient demographics and hospital productivity were accounted for.
Professor Giuseppe Moscelli, the lead researcher, emphasized that the loss of skilled nurses has tangible, life-threatening consequences. He pointed out the crucial role migrant nurses play in delivering high-quality emergency care and stressed the need for policies that bolster the training and retention of domestically trained healthcare professionals. The study underscores the NHS’s reliance on foreign-trained nurses and advocates balancing this dependency through strategic workforce development to ensure future care standards.
This research emphasizes the broader implications of immigration policies on healthcare outcomes and the importance of maintaining a stable, well-qualified nursing workforce. For more details, visit here.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
US Cancer Survivors Reach 18.6 Million and Projected to Surpass 22 Million by 2035
The U.S. cancer survivor population is projected to grow from 18.6 million in 2025 to over 22 million by 2035, highlighting the need for equitable care and survivorship support.
Potential of Anti-Malarial Drugs in Promoting Weight Loss: New Research Findings
Research reveals that anti-malarial drugs like halofuginone may help promote weight loss by regulating appetite and energy metabolism through GDF15 and FGF21 pathways. This innovative approach, rooted in traditional Chinese medicine, offers promising new options for obesity treatment.
Four States Urge FDA to Relax Restrictions on Mifepristone, the Abortion Pill
Four states have petitioned the FDA to remove restrictions on mifepristone, citing its proven safety for medication abortions and seeking to improve access for patients nationwide.